Genesis Energy Earnings: What To Look For From GEL

Genesis Energy (NYSE: GEL) reports earnings Thursday. Last quarter, it posted revenue of $446.6 million, up 12.1% year on year, but missed analysts on EPS and EBITDA. For the upcoming quarter, analysts expect revenue growth of 11.7% year on year. The article cites an average analyst price target of $18.67 versus $15.10.

Original reporting
Published Aug 5, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 4:45 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Genesis Energy Earnings: What To Look For From GEL — source image
Decision brief

The 30-second read

$GELNeutralMed
01

Why it matters

The main tradable element is positioning into the earnings release based on consensus revenue growth expectations and the company’s recent tendency to miss revenue estimates.

02

Market read

Pre-earnings expectations for GEL are framed around a revenue growth reversal, recent estimate-miss history, and peer read-across from upstream and integrated names.

03

What to watch

It does not provide the specific magnitude of the upcoming EPS/EBITDA gap or any new company-specific guidance, so traders may be over-weighting price-target optimism versus the historical pattern of misses.

Relevance 4/10Novelty 4/10Timing: pre-market today ahead of Thursday morning earnings

Background

Genesis Energy (GEL) is described as reporting earnings Thursday morning, following a prior quarter with revenue growth but EPS and EBITDA estimate misses.

Company-level read

Ticker impact

$GELNeutralMedium confidence
Context

Genesis Energy is set to report earnings Thursday, with the article citing recent revenue/EPS/EBITDA misses and current consensus growth expectations.

Expected impact

Likely elevated volatility around the earnings release, with upside/downside dependent on whether revenue growth and profitability metrics re-align with expectations.

Evidence & confidence

No new guidance or datapoint is disclosed beyond what the market expects and prior misses; however, the earnings timing and the stated estimate gaps can influence near-term trading behavior.

Market effects

Upstream and integrated peers are referenced as having mixed results, which can affect read-across expectations for midstream demand and sentiment.

No specific regional market impact is provided.

No explicit global macro or commodity linkage is provided beyond sector sentiment.

Counterpoint

The article highlights multiple revenue estimate misses over two years, so the consensus revenue growth rebound may be fragile if margins or volumes disappoint again.

Key entities

  • Genesis Energy

    NYSE-listed midstream energy infrastructure company scheduled to report earnings Thursday morning.

  • Expand Energy

    Peer cited as having reported Q2 revenue down year over year but beating analysts’ expectations.

  • Kinder Morgan

    Peer cited as having reported Q2 revenue up year over year and topping estimates.

Related articles

$GELMed

Genesis Energy (NYSE:GEL) Delivers Strong Q2 CY2026 Numbers

Genesis Energy (NYSE:GEL) reported Q2 2026 results. Revenue rose 41% year on year to $532 million, beating Wall Street estimates by 26.2%, and GAAP profit was $0.26 per share above consensus. The article also cites adjusted EBITDA margin of 32.2% and free cash flow margin averaging -2.8% over five years, with shares up 2.4% to $15.21 after the release.

$GELMedAI 8/10

GENESIS ENERGY LP (GEL): Results of Operations and Financial Condition

GENESIS ENERGY LP (GEL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a90ex9918kearnings_q22026.htm EX-99.1 Document FOR IMMEDIATE RELEASE August 6, 2026 Genesis Energy, L.P. Reports Second Quarter 2026 Results HOUSTON – (BUSINESS WIRE) – Genesis Energy, L.P. (NYSE: GEL) today announced its second quarter results. We generated the followi

$GELMed

Nifty, Sensex Continue to Push Higher: Tuesday Market Report

Tuesday’s BSE saw 2,293 stocks rise, 1,967 fall and 169 unchanged (advance/decline 1.16). On NSE, 83 issues hit 52-week highs while 28 closed at 52-week lows; Nifty Metal, Auto and Pharma led losers, while Nifty IT, FMCG and Media led gainers. Key corporate moves: Sonata Software NCLT-approved merger; Zydus Lifesciences to buy Assertio at $23.50/share; HCLTech invests ₹1,427.25 crore in Sarvam AI.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.